Every year, millions of people are diagnosed with cancer globally; however, current treatments are limited by disease complexity. A study published...
Vous n'êtes pas connecté
Maroc - ONCOLOGYNEWS.COM.AU - A La Une - 11/07/2024 15:41
Researchers show for the first time that engineered human plasma B cells can be used to treat a disease—specifically leukaemia a humanised animal model. The results mark a key step in the realization of ePCs as therapies to treat cancer, auto-immune disorders, and protein deficiency disorders. The results appear July 2 in the journal Molecular Therapy. [...]
Every year, millions of people are diagnosed with cancer globally; however, current treatments are limited by disease complexity. A study published...
Rocket Pharmaceuticals drops despite the FDA's accelerated approval of gene therapy Kresladi in severe leukocyte adhesion deficiency-I, an ultra-rare...
For the millions of people who carry the gene APOE4, the strongest known genetic risk factor for Alzheimer's disease, their brain activity may begin...
A woman with three different autoimmune conditions had all of them treated simultaneously by genetically modifying her immune cells to kill off the...
A woman with three different autoimmune conditions had all of them treated simultaneously by genetically modifying her immune cells to kill off the...
The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling precise correction,...
Our immune cells usually fight off covid-19, but in some cases, things go rogue SCIENCE PHOTO LIBRARY Evidence is mounting that long covid can be...
Our immune cells usually fight off covid-19, but in some cases, things go rogue SCIENCE PHOTO LIBRARY Evidence is mounting that long covid can be...
Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used to treat diseases such as...
PHILADELPHIA–(BUSINESS WIRE) April 1, 2026 –FORE Biotherapeutics, a registration stage company dedicated to developing targeted therapies...